R.PR
REGISTERED-PRINCIPAL REGISTER
08/24/2021
Back to search
Official data from USPTO
OXTHERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OXTHERA
ST13
US500000088576540Class
5, 35, 42
Filing
88576540
Registration
6458608
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
04/29/2022
Trademark type
Word
Nice classes
5, 35, 42
Filing date
08/13/2019
Registration date
08/24/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/24/2021
Last transaction
04/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
11
Owner location
Stockholm, SE
Examiner
LEE, REBECCA ANN
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OxThera Intellectual Property AB
Representatives
Donna J. Bunton NIXON & VANDERHYE P.C.
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in urologynephrologygastroenterologyoncology and immunology and for the treatment of diabetesinfectious diseasesinflammation and metabolic diseasesall for therapeutic use; pharmaceutical preparations for the treatment of kidney stones; pharmaceutical products for the treatment and prevention of kidney diseases in patients with hyperoxaluria
Class 35
Retail store services featuring goods in the fields of pharmaceuticalsmedical preparationsvaccinesnatural remediesdiagnostics and medical devices; goods import-export agencies; sales promotion for others in the fields of pharmaceuticalsmedical preparationsvaccinesnatural remediesdiagnostics and medical devices
Class 42
Scientific and technological servicesresearch and design in the fields of pharmaceuticstissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medicalbiologicalchemical and scientific research; industrial research in the fields of pharmaceuticstissue engineering and regenerative medicine; pharmaceutical research and development; research and development of new products in the nature of new medicines and medical preparations; medical and chemical laboratories; clinical testingconducting clinical trials for others in the fields of pharmaceutical preparationsdrugscell therapygene therapy and cancer therapy; development of new products in the nature of probesreagents and bioassays for industrial and scientific purposes; advisoryconsultancy and information services relating to the provision of the aforesaid mentioned servicesadvisory and consultancy services relating to medicalbiologicalchemical and scientific researchindustrial research in the fields of pharmaceuticstissue engineering and regenerative medicinepharmaceutical research and development and conducting clinical trials and providing information in the fields of medical researchbiological researchchemical researchscientific research and industrial research in the fields of pharmaceuticstissue engineering and regenerative medicine
Publications
History of USPTO decisions and trademark events.
47 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/19/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
05/03/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/30/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/29/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/29/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/29/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/29/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/29/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/29/2021
OTHE
CASE RETURNED TO EXAMINATION
04/29/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/29/2021
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
04/15/2021
APET
ASSIGNED TO PETITION STAFF
04/12/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/12/2021
EX1G
SOU EXTENSION 1 GRANTED
01/11/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/11/2021
EXT1
SOU EXTENSION 1 FILED
12/23/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/23/2020
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
12/23/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/30/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2020
PUBO
PUBLISHED FOR OPPOSITION
05/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2020
ALIE
ASSIGNED TO LIE
03/26/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/20/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/20/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/20/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/20/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/20/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/21/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/21/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/21/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/21/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/21/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/21/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/19/2019
GNRT
NON-FINAL ACTION E-MAILED
11/19/2019
CNRT
NON-FINAL ACTION WRITTEN
11/19/2019
DOCK
ASSIGNED TO EXAMINER
11/13/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/29/2019
NWAP
NEW APPLICATION ENTERED
08/16/2019
Continuous trademark protection
Get notified about every new filing that threatens OXTHERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.